Hoverink Biotechnologies, Inc. - FORM 10-Q - EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - October 13, 2017

Attached files

file filename
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Hoverink Biotechnologies, Inc.hrnk_ex311.htm
10-Q - QUARTERLY REPORT - Hoverink Biotechnologies, Inc.hrnk_10q.htm
 
Exhibit 32.1
 
CERTIFICATION PURSUANT TO SECTION 906
 
 
Pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, the undersigned officer of Hoverink Biotechnologies, Inc. (the "Company"), hereby certify to my knowledge that:
 
The Report on Form 10-Q for the quarter ended September 30,2017 of the Company fully complies, in all material respects, with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Report fairly represents, in all material respects, the financial condition and results of operations of the Company.
 
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
 
Date: October 13, 2017
 
/s/ Debbie Mae Carter
Director, Chief Executive
Officer Chief Financial Officer and
Principal Accounting Officer
 
 
 

Hoverink Biotechnologies, Inc. Reports